Claret Asset Management Corp

Source: SEC Form 13F · as of Mar 2026

Claret Asset Management Corp holds 33 biotech & pharma companies tracked by BioSniper, totaling $118K in value as of Mar 2026 (SEC Form 13F).

Companies held

33

Total value held

$118K

CompanySharesValue
ABBVAbbVie Inc.115,307$25K
INDVIndivior Pharmaceuticals, Inc.707,267$22K
JNJJOHNSON & JOHNSON58,479$14K
MRKMerck & Co., Inc.114,010$14K
BMYBRISTOL MYERS SQUIBB CO189,930$12K
PFEPFIZER INC288,881$8K
NVONovo Nordisk A/S157,347$6K
CAHCardinal Health Inc.20,559$4K
MCKMcKesson Corporation4,324$4K
AMGNAMGEN INC4,886$2K
ZBHZimmer Biomet Holdings Inc.10,839$980
IQVIQVIA Holdings Inc.4,524$772
UTHRUNITED THERAPEUTICS Corp806$478
JAZZJazz Pharmaceuticals plc2,140$405
ELANElanco Animal Health Inc16,017$383
VTRSViatris Inc26,710$361
MEDPMedpace Holdings Inc.735$353
REGNREGENERON PHARMACEUTICALS, INC.439$339
GMEDGlobus Medical Inc.3,907$337
BIIBBIOGEN INC.1,834$336
LLYELI LILLY & Co318$293
HALOHALOZYME THERAPEUTICS, INC.4,316$279
CORCencora Inc.844$265
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.1,525$263
WSTWest Pharmaceutical Services Inc.1,046$262
NBIXNEUROCRINE BIOSCIENCES INC1,923$253
DGXQuest Diagnostics Incorporated1,288$252
IDXXIDEXX LABORATORIES INC /DE442$249
DVADaVita Inc.1,616$248
BMRNBIOMARIN PHARMACEUTICAL INC4,149$234
TECHBIO-TECHNE Corp4,415$231
ZTSZoetis Inc.1,912$226
RGENREPLIGEN CORP1,853$218

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Claret Asset Management Corp — Biotech 13F Holdings & Portfolio | BioSniper